The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Genomic Testing Market Research Report 2025
Synopsis
The global Cancer Genomic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Genomic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Genomic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Genomic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Genomic Testing include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Genomic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genomic Testing.
Report Scope
The Cancer Genomic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Genomic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Genomic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
Segment by Type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genomic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cancer Genomic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Genomic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Genomic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Genomic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Genomic Testing include Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience and Bio-Rad Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Genomic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Genomic Testing.
Report Scope
The Cancer Genomic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Genomic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Genomic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
Segment by Type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Genomic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Breast Cancer Genomic Testing
1.2.3 Lung Cancer Genomic Testing
1.2.4 Blood Cancer Genomic Testing
1.2.5 Liver Cancer Genomic Testing
1.2.6 Stomach Cancer Genomic Testing
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Genomic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.3.5 Academic and Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genomic Testing Market Perspective (2019-2030)
2.2 Cancer Genomic Testing Growth Trends by Region
2.2.1 Global Cancer Genomic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Genomic Testing Historic Market Size by Region (2019-2024)
2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2025-2030)
2.3 Cancer Genomic Testing Market Dynamics
2.3.1 Cancer Genomic Testing Industry Trends
2.3.2 Cancer Genomic Testing Market Drivers
2.3.3 Cancer Genomic Testing Market Challenges
2.3.4 Cancer Genomic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genomic Testing Players by Revenue
3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2019-2024)
3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
3.4 Global Cancer Genomic Testing Market Concentration Ratio
3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2023
3.5 Cancer Genomic Testing Key Players Head office and Area Served
3.6 Key Players Cancer Genomic Testing Product Solution and Service
3.7 Date of Enter into Cancer Genomic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genomic Testing Breakdown Data by Type
4.1 Global Cancer Genomic Testing Historic Market Size by Type (2019-2024)
4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2025-2030)
5 Cancer Genomic Testing Breakdown Data by Application
5.1 Global Cancer Genomic Testing Historic Market Size by Application (2019-2024)
5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Genomic Testing Market Size (2019-2030)
6.2 North America Cancer Genomic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Genomic Testing Market Size by Country (2019-2024)
6.4 North America Cancer Genomic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Genomic Testing Market Size (2019-2030)
7.2 Europe Cancer Genomic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Genomic Testing Market Size by Country (2019-2024)
7.4 Europe Cancer Genomic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genomic Testing Market Size (2019-2030)
8.2 Asia-Pacific Cancer Genomic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Genomic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Genomic Testing Market Size (2019-2030)
9.2 Latin America Cancer Genomic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Genomic Testing Market Size by Country (2019-2024)
9.4 Latin America Cancer Genomic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genomic Testing Market Size (2019-2030)
10.2 Middle East & Africa Cancer Genomic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Genomic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Detail
11.1.2 Myriad Genetics Business Overview
11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2019-2024)
11.1.5 Myriad Genetics Recent Development
11.2 Centogene AG
11.2.1 Centogene AG Company Detail
11.2.2 Centogene AG Business Overview
11.2.3 Centogene AG Cancer Genomic Testing Introduction
11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2019-2024)
11.2.5 Centogene AG Recent Development
11.3 Color Genomics
11.3.1 Color Genomics Company Detail
11.3.2 Color Genomics Business Overview
11.3.3 Color Genomics Cancer Genomic Testing Introduction
11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2019-2024)
11.3.5 Color Genomics Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 23andMe Inc.
11.5.1 23andMe Inc. Company Detail
11.5.2 23andMe Inc. Business Overview
11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2019-2024)
11.5.5 23andMe Inc. Recent Development
11.6 Gene By Gene Ltd.
11.6.1 Gene By Gene Ltd. Company Detail
11.6.2 Gene By Gene Ltd. Business Overview
11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2019-2024)
11.6.5 Gene By Gene Ltd. Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Detail
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Cancer Genomic Testing Introduction
11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2019-2024)
11.7.5 LabCorp Recent Development
11.8 Positive Bioscience
11.8.1 Positive Bioscience Company Detail
11.8.2 Positive Bioscience Business Overview
11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2019-2024)
11.8.5 Positive Bioscience Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Detail
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2019-2024)
11.10.5 Illumina, Inc. Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Breast Cancer Genomic Testing
Table 3. Key Players of Lung Cancer Genomic Testing
Table 4. Key Players of Blood Cancer Genomic Testing
Table 5. Key Players of Liver Cancer Genomic Testing
Table 6. Key Players of Stomach Cancer Genomic Testing
Table 7. Key Players of Others
Table 8. Global Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cancer Genomic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Cancer Genomic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Cancer Genomic Testing Market Share by Region (2019-2024)
Table 12. Global Cancer Genomic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Cancer Genomic Testing Market Share by Region (2025-2030)
Table 14. Cancer Genomic Testing Market Trends
Table 15. Cancer Genomic Testing Market Drivers
Table 16. Cancer Genomic Testing Market Challenges
Table 17. Cancer Genomic Testing Market Restraints
Table 18. Global Cancer Genomic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Cancer Genomic Testing Market Share by Players (2019-2024)
Table 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2023)
Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Genomic Testing Product Solution and Service
Table 25. Date of Enter into Cancer Genomic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Genomic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Cancer Genomic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Cancer Genomic Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Cancer Genomic Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cancer Genomic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cancer Genomic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Cancer Genomic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Cancer Genomic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Cancer Genomic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Cancer Genomic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Cancer Genomic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Cancer Genomic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Cancer Genomic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Cancer Genomic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Cancer Genomic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cancer Genomic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Myriad Genetics Company Detail
Table 51. Myriad Genetics Business Overview
Table 52. Myriad Genetics Cancer Genomic Testing Product
Table 53. Myriad Genetics Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 54. Myriad Genetics Recent Development
Table 55. Centogene AG Company Detail
Table 56. Centogene AG Business Overview
Table 57. Centogene AG Cancer Genomic Testing Product
Table 58. Centogene AG Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 59. Centogene AG Recent Development
Table 60. Color Genomics Company Detail
Table 61. Color Genomics Business Overview
Table 62. Color Genomics Cancer Genomic Testing Product
Table 63. Color Genomics Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 64. Color Genomics Recent Development
Table 65. Quest Diagnostics Company Detail
Table 66. Quest Diagnostics Business Overview
Table 67. Quest Diagnostics Cancer Genomic Testing Product
Table 68. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 69. Quest Diagnostics Recent Development
Table 70. 23andMe Inc. Company Detail
Table 71. 23andMe Inc. Business Overview
Table 72. 23andMe Inc. Cancer Genomic Testing Product
Table 73. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 74. 23andMe Inc. Recent Development
Table 75. Gene By Gene Ltd. Company Detail
Table 76. Gene By Gene Ltd. Business Overview
Table 77. Gene By Gene Ltd. Cancer Genomic Testing Product
Table 78. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 79. Gene By Gene Ltd. Recent Development
Table 80. LabCorp Company Detail
Table 81. LabCorp Business Overview
Table 82. LabCorp Cancer Genomic Testing Product
Table 83. LabCorp Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 84. LabCorp Recent Development
Table 85. Positive Bioscience Company Detail
Table 86. Positive Bioscience Business Overview
Table 87. Positive Bioscience Cancer Genomic Testing Product
Table 88. Positive Bioscience Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 89. Positive Bioscience Recent Development
Table 90. Bio-Rad Laboratories Company Detail
Table 91. Bio-Rad Laboratories Business Overview
Table 92. Bio-Rad Laboratories Cancer Genomic Testing Product
Table 93. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 94. Bio-Rad Laboratories Recent Development
Table 95. Illumina, Inc. Company Detail
Table 96. Illumina, Inc. Business Overview
Table 97. Illumina, Inc. Cancer Genomic Testing Product
Table 98. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 99. Illumina, Inc. Recent Development
Table 100. Agilent Technologies Company Detail
Table 101. Agilent Technologies Business Overview
Table 102. Agilent Technologies Cancer Genomic Testing Product
Table 103. Agilent Technologies Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 104. Agilent Technologies Recent Development
Table 105. Thermo Fisher Scientific Company Detail
Table 106. Thermo Fisher Scientific Business Overview
Table 107. Thermo Fisher Scientific Cancer Genomic Testing Product
Table 108. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2019-2024) & (US$ Million)
Table 109. Thermo Fisher Scientific Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genomic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Genomic Testing Market Share by Type: 2023 VS 2030
Figure 3. Breast Cancer Genomic Testing Features
Figure 4. Lung Cancer Genomic Testing Features
Figure 5. Blood Cancer Genomic Testing Features
Figure 6. Liver Cancer Genomic Testing Features
Figure 7. Stomach Cancer Genomic Testing Features
Figure 8. Others Features
Figure 9. Global Cancer Genomic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Cancer Genomic Testing Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Diagnostic Laboratories Case Studies
Figure 14. Academic and Research Institutes Case Studies
Figure 15. Others Case Studies
Figure 16. Cancer Genomic Testing Report Years Considered
Figure 17. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Cancer Genomic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Cancer Genomic Testing Market Share by Region: 2023 VS 2030
Figure 20. Global Cancer Genomic Testing Market Share by Players in 2023
Figure 21. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2023
Figure 23. North America Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Cancer Genomic Testing Market Share by Country (2019-2030)
Figure 25. United States Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Cancer Genomic Testing Market Share by Country (2019-2030)
Figure 29. Germany Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Cancer Genomic Testing Market Share by Region (2019-2030)
Figure 37. China Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Cancer Genomic Testing Market Share by Country (2019-2030)
Figure 45. Mexico Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Cancer Genomic Testing Market Share by Country (2019-2030)
Figure 49. Turkey Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 52. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 53. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 54. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 55. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 56. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 57. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 58. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 60. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 61. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
